Pharmigene, Inc. (TPEX:7595)
11.45
0.00 (0.00%)
Jul 11, 2025, 9:09 AM CST
Pharmigene Company Description
Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.
It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications.
The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services.
In addition, it distributes various genomics and genetics equipment and reagents; and provides professional consultation, training program, analysis software, and technical support solutions.
Further, the company offers CDMO services. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
Pharmigene, Inc.
Country | Taiwan |
Founded | 1994 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Fuhui Zhan |
Contact Details
Address: No. 17, Lane 171, Section 2, Jiuzong Road Taipei, 114066 Taiwan | |
Phone | 886 2 2798 5885 |
Website | pharmigene.com.tw |
Stock Details
Ticker Symbol | 7595 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0007595B13 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Fuhui Zhan | Chief Executive Officer |
Guanzhi Chen | Chief Operating Officer |